BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8769976)

  • 1. Quadruple immunosuppression in a pig model of small bowel transplantation.
    Gruessner RW; Fasola C; Fryer J; Nakhleh RE; Kim S; Gruessner AC; Beebe D; Moon C; Troppmann C; Najarian JS
    J Surg Res; 1996 Feb; 61(1):260-6. PubMed ID: 8769976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of FK506 versus CsA and pig ATG in a porcine model of small bowel transplantation.
    Gruessner RW; Fryer JP; Fasola C; Nakhleh RE; Gruessner AC; Kim S; Dunn DL; Pirenne J; Bekersky I; Benedetti E
    Transplantation; 1995 Jan; 59(2):164-71. PubMed ID: 7530871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological protection of small bowel by simultaneously transplanted liver graft in pigs.
    Yin ZY; Li N; Wang XM; Ni XD; Jiang F; Li YS; Li JS
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):363-9. PubMed ID: 19666404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
    J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
    Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
    Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel rejection in isolated small bowel transplantation and in multivisceral transplantation: a comparative study in a large animal model.
    Nishida S; Komokata T; Ogata S; Ikoma A; Hamada N; Tanaka K; Yoshida H; Taira A
    In Vivo; 1998; 12(2):259-66. PubMed ID: 9627811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?
    Soin AS; Rasmussen A; Jamieson NV; Watson CJ; Friend PJ; Wight DG; Calne RY
    Transplantation; 1995 Apr; 59(8):1119-23. PubMed ID: 7732557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
    J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of rejection and graft loss with an aggressive quadruple immunosuppressive therapy regimen in children and adolescents.
    Conley SB; al-Uzri A; So S; Salvatierra O
    Transplantation; 1994 Feb; 57(4):540-4. PubMed ID: 8116038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study.
    Oertel M; Sack U; Kohlhaw K; Lehmann I; Emmrich F; Berr F; Hauss J; Schwarz R
    Transpl Int; 2002 Oct; 15(9-10):463-71. PubMed ID: 12389078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B
    Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow augmentation in kidney transplantation: a large animal study.
    Gruessner RW; Zhang KY; Dunning M; Nakhleh RE; Gruessner AC
    Transpl Int; 2001 Jun; 14(3):159-69. PubMed ID: 11499905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-dose antithymocyte globulins in kidney transplantation: results of a protocol of intermittent administration].
    Mourad G; Portales P; Garrigue V; Djamali A; Bouloux C; Chong G; Clot J
    Nephrologie; 2000; 21(5):253-8. PubMed ID: 11068775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small bowel transplantation: current progress and clinical application.
    Frezza EE; Tzakis A; Fung JJ; Van Thiel DH
    Hepatogastroenterology; 1996; 43(8):363-76. PubMed ID: 8714229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of surgery, immunosuppressive drugs, and rejection, on graft function after small bowel transplantation: a large-animal study.
    Alessiani M; De Ponti F; Fayer F; Abbiati F; Zonta S; Zitelli E; Arbustini E; Morbini P; Poggi N; Klersy C; Blangetti I; Dionigi P; Zonta A
    Transpl Int; 2003 May; 16(5):327-35. PubMed ID: 12759724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.